The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon
about
Autophagy in colorectal cancer: An important switch from physiology to pathologyNew frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targetsAssociation between pre-miR-27a functional polymorphism and risk of colorectal cancer in north Chinese Han population.The T300A Crohn's disease risk polymorphism impairs function of the WD40 domain of ATG16L1.Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based studyMay autophagy be a novel biomarker and antitumor target in colorectal cancer?Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis.A functional ATG16L1 (T300A) variant is associated with necrotizing enterocolitis in premature infants.The Protective Role of Type I Interferons in the Gastrointestinal Tract.The interplay between autophagy and tumorigenesis: exploiting autophagy as a means of anticancer therapy.[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling.Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells.Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species.Drosophila Atg16 promotes enteroendocrine cell differentiation via regulation of intestinal Slit/Robo signaling.Mechanisms and function of autophagy in intestinal disease.The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer.Herpesvirus-encoded microRNAs detected in human gingiva alter host cell transcriptome and regulate viral infection.[Contribution of autophagy to intestinal homeostasis and pathology].Establishment and Characterization of Paired Primary and Peritoneal Seeding Human Colorectal Cancer Cell Lines: Identification of Genes That Mediate Metastatic Potential
P2860
Q26776207-B5A72D49-FB4A-4A4E-8B6F-117E54CC4FA1Q33731804-B7F959DD-4ABC-451A-A863-8F8362E729CFQ36208406-AB0B07E4-1A2D-449F-AC8B-D95E41986A55Q36986458-DAFB1578-60EB-4ADC-A104-EA604E421698Q37430032-067616C7-80A5-413B-A5D2-3C96337026B4Q38954048-C859A0A0-76E3-4558-A91D-982A714E9ACCQ38970279-6FB86153-43FB-495E-AD36-464D3DD1C1C7Q39148501-F29D2BEE-C136-4957-ADDE-B5DE140ADEFDQ39253724-C1815D05-454C-49B5-BF0F-896650235718Q39278658-12EF060A-F039-406C-AB37-F75FCA54DB2CQ39888747-9179A050-6358-4EFD-9812-8F89A1D680FCQ41701341-A0E5351B-7A7E-4423-A3F7-95A681D9DADEQ46238888-F2C5EEFC-2082-461E-87C6-8BF6A681C930Q47690721-382C6772-C56B-4FA8-933D-FD5F90713956Q50052566-840E13B0-49D2-44D4-8CD0-FE8A7C0BF08EQ52097466-A327940C-8F38-4678-88AF-97B37D4567CDQ52351840-71CBA109-BB72-49E3-8EF1-CA9707CD37A0Q52693138-5FEF1982-70A5-4E36-87BF-10294C668B6AQ58782067-14E001BA-72B9-4748-9C02-916E8D944DAE
P2860
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Thr300Ala variant in ATG16 ...... roduction of type I interferon
@ast
The Thr300Ala variant in ATG16 ...... roduction of type I interferon
@en
type
label
The Thr300Ala variant in ATG16 ...... roduction of type I interferon
@ast
The Thr300Ala variant in ATG16 ...... roduction of type I interferon
@en
prefLabel
The Thr300Ala variant in ATG16 ...... roduction of type I interferon
@ast
The Thr300Ala variant in ATG16 ...... roduction of type I interferon
@en
P2093
P2860
P1433
P1476
The Thr300Ala variant in ATG16 ...... roduction of type I interferon
@en
P2093
Amanda Springer
Brooke E Sylvester
David L Boone
Dezheng Huo
James P Lodolce
Marc Bissonnette
Mark F Logsdon
Nathan Ellis
Sarah Bartulis
Sonia S Kupfer
P2860
P304
P356
10.1136/GUTJNL-2014-308735
P407
P577
2015-02-02T00:00:00Z